Skip to main content

Table 1 PSP/reg and NT-proCNP doses (ng/ml) in function of patient groups

From: PSP/reg and NT-proCNP to predict the occurrence of ICU-acquired sepsis in severe trauma patients: results of a pilot study

  

Sepsis

Nonsepsis

PSP/reg

Days 1 to 2 (n = 38)

(n = 16) 30.1 (15.9; 51.4)

(n = 22) 27.8 (18.0; 41.3)

 

Days 3 to 4 (n = 36)

(n = 7) 57.9 (21.7; 131.1)

(n = 29) 38.5 (15.8; 71.2)

NT-proCNP

Days 1 to 2 (n = 37)

(n = 16) 4.5 (3.6; 5.7)

(n = 21) 5 (3.8; 8.8)

 

Days 3 to 4 (n = 36)

(n = 7) 3.6 (3.3; 3.9)

(n = 29) 4.7 (3.3; 5.6)

  1. Data presented as median (Q1; Q3).